On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

In recent years, the conversation surrounding cannabis and its medicinal properties has gained considerable momentum.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

Astronauts commonly reported acute and chronic pain during and after spaceflight, particularly in the lumbar spine. During and after spaceflight, astronauts experience lower back pain (LBP ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

Vertex isn’t pursuing the FDA’s approval for suzetrigine to treat chronic pain — a ... show suzetrigine doesn’t block acute ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...